SM
PFE icon

Sabby Management’s Pfizer PFE Stock Holding History

Sabby Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,814
Closed -$9.29M – 352
2015
Q1 		$9.29M Sell
2,814
-19,122
-87% -$608K 0.39% 49
2014
Q4 		$64.8K Buy
+21,936
New +$629K 2.05% 11
2014
Q2 		– Sell
-685
Closed -$2.09M – 283
2014
Q1 		$2.09M Buy
+685
New +$20.4K 0.12% 103

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sabby Management's PFE Position: Q1 2015 in Review

Sabby Management sold out of Pfizer (PFE) in Q1 2015, closing a stake of 1,322,658 shares — an estimated $42.1M sold.

Sabby Management first reported a position in PFE in Q4 2014 and held it in 1 quarter. The position peaked at $39.1K in Q4 2014. 1,875 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

  • Sabby Management reported no remaining Pfizer position as of Q1 2015 after selling out during the quarter.
  • Sabby Management sold 1,322,658 Pfizer shares in Q1 2015, an estimated $42.1M.
  • Sabby Management first reported a position in Pfizer in Q4 2014 and held it in 1 quarter.
  • Sabby Management's Pfizer position peaked at $39.1K in Q4 2014.
  • 1,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Sabby Management's 13F filing for Q1 2015, filed 15 May 2015.